Editas Medicine, Inc.
Ticker: 1650664
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 11.89+320.1% | 2.83-62.5% | 7.54+110.6% | 3.58-23.2% | 4.66+7666.7% | 0.06-88.2% | 0.51-55.3% | 1.14 |
| Total Income | 11.89+320.1% | 2.83-62.5% | 7.54+110.6% | 3.58-23.2% | 4.66+7666.7% | 0.06-88.2% | 0.51-55.3% | 1.14 |
| EXPENSES | ||||||||
| Expenditure | 30.44+9.4% | 27.83-13.3% | 32.09-41.8% | 55.12-31.8% | 80.82+23.0% | 65.73-9.2% | 72.42+6.3% | 68.13 |
| PROFIT | ||||||||
| Net Profit | -18.23+27.0% | -24.98+0.6% | -25.12+52.8% | -53.24+30.0% | -76.09-22.4% | -62.14+8.1% | -67.61-9.1% | -61.95 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.15+42.3% | -0.26+7.1% | -0.28+55.6% | -0.63+31.5% | -0.92-22.7% | -0.75+8.5% | -0.82-7.9% | -0.76 |
Corporate Events
Board MeetingEDIT
202617Jun
Board Meeting
2026 Annual Meeting of Stockholders to elect Class I directo…
SEC Filing ↗